Skip to content

Dr LIN Jie

Active
Private limited companyfounded 2019active for 7 yearsBelliardstraat 201, 1040 Brussel, BelgiumKBO/BCE: BE 0731.566.377
Summary

Dr LIN Jie has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,333 and a net result of €66,194. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 10% of 3,032 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 24-07-2019 Normal situation
Registered office
10 active companies are registered at this address Source: KBO register, as of 2 November 2026.
Activity
General medical practice NACE 86210and 2 others
Establishment unit
2.292.646.072 1040 Brussel, since 24-07-2019
Financial year end
31 December
Peppol
Reachable since 20-11-2025

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€89,438
▲ 16.2%
Turnover
≈ €220,000
estimated
Profit
€66,194
▲ 18.4%
Equity
€3,333
▼ 35.1%
Total assets
€72,801
▼ 35.4%
Score breakdownraises riskEquity €3,333 (4.6% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.91, cash €54,065Size: total assets €72,801Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 32% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 30=
equity 4.6% of total assets
Liquidity 50=
short-term debt 95.4% · cash 74.3%
Profitability 100=
return on assets 90.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 10% of them on solvency, 20% on liquidity, 80% on profitability and 16% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.91, cash €54,065
NBB · annual accounts
lowers risk · Size: total assets €72,801
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €3,333 (4.6% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 3032 sector peers (2025).
NBB · sector comparison
Position among 3032 sector peers
Solvency
better than 10%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
43 days early
2024
48 days early
2023
68 days late
2022
16 days late
2021
61 days late
2020
17 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 12 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 August (4 of the last 5 accounts filed within 59 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Less equity than 94% of companies in human healthsector median €367,072 · 3,032 companies €3,333 View

Recent changes

  1. · Gazette deed Incorporation
All 9 events

Comparable companies

These companies have the same main activity as Dr LIN Jie: general medical practice (NACE 86210). They are comparable in size and age: total assets between €70,800 and €82,000, founded between 2018 and 2020.

CompanyTotal assetsGross margin
Dr LIN Jie Brussel€72,801€89,438
DR BOCHOUARI ZINEB Charleroi€74,742€81,925
Dr. Viaene Laurence Kuurne€72,467€80,984
Dr. COVELIERS Chaudfontaine€77,347€90,166
L. Creemers Lummen€82,050€84,150
DR. EVELYN WINNE Jabbeke€70,836€92,570
Dokter Tans Céline Zonhoven€73,455€96,277
Full comparison

Key facts about Dr LIN Jie

What is the company number of Dr LIN Jie?
The company number of Dr LIN Jie is 0731.566.377. The VAT number is the same number with BE in front: BE 0731.566.377.
Where is Dr LIN Jie based?
The registered office is at Belliardstraat 201, 1040 Brussel.Company details
What does Dr LIN Jie do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr LIN Jie?
The legal form of Dr LIN Jie is Private limited company (BV).
When was Dr LIN Jie founded?
Dr LIN Jie was founded on 24-07-2019.
Is Dr LIN Jie still active?
Yes, Dr LIN Jie is an active enterprise in the KBO register.
What is the turnover of Dr LIN Jie?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €89,438 and 47 comparable companies (NACE 862). It probably lies between €160,000 and €330,000.Financials
Is Dr LIN Jie profitable?
In financial year 2025, Dr LIN Jie made a profit of €66,194.
Where can I find the annual accounts of Dr LIN Jie?
Dr LIN Jie filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr LIN Jie due?
Dr LIN Jie must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.